meta_pixel
Tapesearch Logo
Log in
Science Quickly

Your Next Pain Prescription Could Come without Addiction Risk

Science Quickly

Scientific American

Science

4.41.4K Ratings

🗓️ 2 October 2024

⏱️ 11 minutes

🧾️ Download transcript

Summary

The Food and Drug Administration has granted priority review to suzetrigine, a novel painkiller. It’s part of a new class of medications that could provide relief to those with chronic pain. The drugs target sodium channels on nerve cells, stopping pain signaling at the periphery. Journalist Marla Broadfoot explains the biology of aches and pains and the reasons it is so challenging to develop well-tolerated medications for pain. Recommended reading: New Painkiller Could Bring Relief to Millions—Without Addiction Risk  Ozempic Quiets Food Noise in the Brain—But How?  E-mail us at sciencequickly@sciam.com if you have any questions, comments or ideas for stories we should cover! Discover something new every day: subscribe to Scientific American and sign up for Today in Science, our daily newsletter.  Science Quickly is produced by Rachel Feltman, Fonda Mwangi, Kelso Harper, Madison Goldberg and Jeff DelViscio. This episode was hosted by Rachel Feltman with guest Marla Broadfoot. Shayna Posses and Aaron Shattuck fact-check our show. The theme music was composed by Dominic Smith. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

Here's the truth about AI.

0:02.0

AI is only as powerful as the platform it's built into.

0:05.0

ServiceNow puts AI to work for people across your business,

0:09.0

removing friction and frustration for your employees,

0:12.0

supercharging productivity for your developers,

0:15.0

providing intelligent tools for your service agents to make customers happier.

0:19.0

All built into a single platform you can

0:21.9

use right now. That's why the world works with ServiceNow. Visit ServiceNow.com

0:27.8

slash UK slash AI for people. Almost all humans experience pain in some form or another during their

0:35.7

lives. And for many folks, pain is a frequent or even

0:40.2

constant companion. A National Institutes of Health Study published last year reported that about 21%

0:47.4

of U.S. adults experienced chronic pain in 2020. And while there are many medications out there to help people cope with pain,

0:56.2

they can often cause their own headaches, to say the very least. Now a pharmaceutical company

1:02.2

is potentially on the cusp of releasing a brand new type of pain medication, one that works to

1:08.7

block pain signals like opioids do, but without impacting the brain or spinal cord

1:13.9

in ways that can lead to addiction. For science quickly, I'm Rachel Feltman. I'm joined today by

1:19.3

Marla Broadfoot, a freelance science journalist who recently covered the new drug for Scientific American.

1:26.3

Marla, thank you so much for joining us today. Happy to be here.

1:29.9

So let's start with a pretty basic question, though I think kind of a complicated one too.

1:35.5

When we talk about pain, what is it physiologically? Yeah, that's a great question. So pain is an

1:43.2

unpleasant sensation, often an extremely unpleasant sensation, that is typically there to tell us that there's something wrong with your body. But then we feel pain in cases of chronic pain where there isn't anything wrong. And so physiologically speaking, our body is home to lots and lots of these

2:04.3

pain sensing nerve cells that act like an alarm system. So they'll detect danger in the form of

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Scientific American, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scientific American and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.